ConductScience.org, home

Paper8312679

Acute hepatic failure: limitations of medical treatment and indications for liver transplantation.

Peters M and 2 others. Clin Investig, 1993. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Acute hepatic failure: limitations of medical treatment and indications for liver transplantation. Papers, record 8312679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8312679

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Acute hepatic failure: limitations of medical treatment and indications for liver transplantation.
PubMed
Journal
Clin Investig
PubMed
Year
1993
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.15
iCite
Revised in PubMed
2026-10-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Peters MM
2Meyer zum Büschenfelde KHK H
3Gerken GG

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatic EncephalopathyMajor topic
Liver TransplantationMajor topic
Humans
Prognosis

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12010156Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease.Hepatology1991https://conductscience.org/library/papers/2010156PubMed
21592344Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure.Hepatology1992https://conductscience.org/library/papers/1592344PubMed
31968130Transplantation for fulminant hepatic failure.Lancet1990https://conductscience.org/library/papers/1968130PubMed
48425701T-lymphocyte response to hepatitis C virus in different clinical courses of infection.Gastroenterology1993https://conductscience.org/library/papers/8425701PubMed
53086979Serologic markers of hepatitis B virus infection.Semin Liver Dis1986https://conductscience.org/library/papers/3086979PubMed
61893819Hepatocyte transplantation. A potential treatment for liver disease.Dig Dis Sci1991https://conductscience.org/library/papers/1893819PubMed
71618463Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure.Hepatology1992https://conductscience.org/library/papers/1618463PubMed
81553926Liver transplantation for viral hepatitis: current status.Am J Gastroenterol1992https://conductscience.org/library/papers/1553926PubMed
93552924Orthotopic liver transplantation for acute and subacute hepatic failure in adults.Hepatology1987https://conductscience.org/library/papers/3552924PubMed
101649403Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.N Engl J Med1991https://conductscience.org/library/papers/1649403PubMed
114448416Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure.Gut1974https://conductscience.org/library/papers/4448416PubMed
121967338Liver transplantation for acute hepatic failure?Lancet1990https://conductscience.org/library/papers/1967338PubMed
131860679Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis.Hepatology1991https://conductscience.org/library/papers/1860679PubMed
147262632Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis.Gut1981https://conductscience.org/library/papers/7262632PubMed
153057060Transplantation of the liver in adults and children with fulminant hepatic failure.J Hepatol1988https://conductscience.org/library/papers/3057060PubMed
161904133Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure.N Engl J Med1991https://conductscience.org/library/papers/1904133PubMed
171867529Bioartificial liver using hepatocytes on biosilon microcarriers: treatment of chemically induced acute hepatic failure in rats.Artif Organs1991https://conductscience.org/library/papers/1867529PubMed
181348798Hepatitis B virus and apparent fulminant non-A, non-B hepatitis.Lancet1992https://conductscience.org/library/papers/1348798PubMed
195036671[Brain edema. A cause of death in endogenous hepatic coma].Klin Wochenschr1972https://conductscience.org/library/papers/5036671PubMed
202034247A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.N Engl J Med1991https://conductscience.org/library/papers/2034247PubMed

See all 43 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8312679

GET https://conductscience.org/api/papers/v1/8312679/references?page=2